Hematology Breakfast Briefing 2024
Published on June 11, 2025.
Updated on February 03, 2026.
Briefing
Hosted
Topic
Impact of Recent Publications on CAR-T Use in DLBCL and Multiple Myeloma, and Evolving Treatment Needs in AML.
About
Joining us in conversation will be Dr. Nicolas Blin, a hematologist from the university hospital and CAR-T center of Nantes in France.
Together with Dr. Blin, we will explore the role of CAR-Ts in Multiple Myeloma and DLBCL, and gain his current insights in the treatment of AML/MDS and how this relates to the real-world data captured by APLUSA.
